AUM Pharmacy
Health Hub
Search Icon

AUM Pharmacy

Hi there!

Hello, Login
All Categories
VisaVisaVisa
fallback

Sitadus M 50mg/500mg Tablet

Prescription Icon
Prescription Required

Marketer

Lividus Pharmaceuticals Pvt Ltd

Salt Composition

Sitagliptin (50mg) + Metformin (500mg)

Overview Sitadus M 50mg/500mg Tablet

Metformin/glimepiride 50mg/500mg tablets manage elevated blood glucose in type 2 diabetes patients by combining two active agents. This dual action helps prevent serious diabetic complications like vision loss and kidney disease, potentially lessening heart attack or stroke risk. This medication may be used alone or in conjunction with other diabetes treatments, and is most effective when combined with a balanced diet and regular physical activity. Dosage is personalized based on your health status, glucose levels, and other medications. Taking it with food minimizes stomach upset. Consistent daily use at the same time maximizes efficacy; discontinue only under your physician's guidance. Adherence to your prescribed diet and exercise plan is vital. Lifestyle significantly impacts diabetes control. Common side effects include nausea, diarrhea, vomiting, indigestion, headache, and sore throat. Low blood sugar (hypoglycemia) is a potential side effect, especially when used with insulin or sulfonylureas; learn how to manage this. This medication isn't for everyone. Inform your doctor of any prior kidney, liver, heart, or pancreatic issues, or excessive alcohol consumption before starting. Pregnant or nursing individuals should consult their doctor. Other medications may interact; disclose all medications to ensure safety. Alcohol should be limited due to its blood glucose-lowering effect. Your doctor will monitor kidney function and blood sugar throughout treatment.

Uses of Sitadus M 50mg/500mg Tablet

Managing type 2 diabetes

Major Benefits of Sitadus M 50mg/500mg Tablet:

Consume this medication precisely as directed by your physician, adhering to the prescribed dosage and treatment period. Ingest the entire tablet without chewing, crushing, or fracturing it. The Sitadus M 50mg/500mg Tablet should be administered with a meal.

Common Side effects of Sitadus M 50mg/500mg Tablet:

  • Decreased appetite
  • Vomiting
  • Upper respiratory tract infection
  • Hypoglycemia (low blood glucose level)
  • Abdominal bloating
  • Nausea
  • Diarrhea

How to use Sitadus M 50mg/500mg Tablet:

Consume this medication precisely as prescribed by your physician, adhering to both dosage and treatment length. Ingest the entire tablet; avoid chewing, crushing, or fracturing it. It is recommended to take Sitadus M 50mg/500mg tablets with food.

How Sitadus M 50mg/500mg Tablet works:

Sitagliptin and metformin, combined as Sitadus M 50mg/500mg tablets, work synergistically to manage blood glucose levels. Sitagliptin enhances insulin production by the pancreas, improves insulin utilization, and diminishes hepatic glucose output. Metformin, a biguanide, reduces liver glucose production, slows intestinal glucose absorption, and augments insulin sensitivity. This dual action facilitates superior glycemic control.

SAFETY ADVICE

AlcoholAlcoholUNSAFE

Consuming alcohol while taking Sitadus M 50mg/500mg tablets is unsafe.

PregnancyPregnancyCONSULT YOUR DOCTOR

The use of Sitadus M 50mg/500mg Tablet during pregnancy may pose risks. While human data is scarce, animal research indicates potential harm to a developing fetus. A physician will assess the advantages against possible dangers prior to prescribing. Physician consultation is recommended.

Breast feedingBreast feedingCONSULT YOUR DOCTOR

The use of Sitadus M 50mg/500mg tablets while breastfeeding is likely inadvisable. Available human data indicates potential transfer of the medication into breast milk, posing a possible risk to the infant.

DrivingDrivingCAUTION

Driving may be impaired by excessively low or high blood glucose levels. Refrain from driving if such symptoms arise.

KidneyKidneyCAUTION

Patients with kidney impairment should use Sitadus M 50mg/500mg Tablets cautiously, potentially requiring dosage modification. Consult a physician before use. This medication is contraindicated in individuals with severe kidney disease. Regular monitoring of kidney function is recommended during treatment.

LiverLiverUNSAFE

Individuals with liver conditions should likely refrain from using Sitadus M 50mg/500mg Tablets due to potential safety concerns. Medical advice is recommended.

What if you forget to take Sitadus M 50mg/500mg Tablet :

Should you forget a Sitadus M 50mg/500mg Tablet dose, administer it promptly. Nevertheless, if your next scheduled dose is imminent, omit the missed dose and resume your usual dosing regimen. Avoid taking a double dose.

Facts to Know About Sitadus M 50mg/500mg Tablet

LabelValue
Developing Habits No.
Treatment Category Diabetes Treatment

FAQs on Sitadus M 50mg/500mg Tablet

Sitadus M 50mg/500mg tablets combine sitagliptin and metformin to treat type 2 diabetes in adults. This combination improves blood sugar control when used with diet and exercise. Metformin reduces liver glucose production and enhances insulin sensitivity, while sitagliptin boosts insulin release by inhibiting DPP-4. This medication is not suitable for individuals under 18.
Prolonged use of Sitadus M 50mg/500mg Tablets can lead to vitamin B12 deficiency by hindering its absorption. This deficiency may cause anemia, nerve damage (manifested as tingling, numbness in extremities, weakness, urinary issues, cognitive changes, and ataxia), if left unaddressed. To mitigate this risk, supplemental vitamin B12 is recommended annually by some researchers.
Sitadus M 50mg/500mg tablets may cause common side effects such as hypoglycemia, altered taste, nausea, stomach pain, diarrhea, headache, and upper respiratory tract infections. Rare but serious side effects include lactic acidosis. Prolonged use can also result in vitamin B12 deficiency.
Sitadus M 50mg/500mg Tablets are contraindicated in patients with known allergies to its components or excipients, and in those with severe kidney or liver impairment, congestive heart failure, lactic acidosis, or diabetic ketoacidosis.
Combining Sitadus M 50mg/500mg Tablet with alcohol is unsafe and may heighten the risk of lactic acidosis.
Store this medication in its original, tightly closed container, following the storage instructions on the label. Discard any unused medication and keep it out of reach of children, pets, and others.
Sitagliptin/Metformin (Sitadus M 50mg/500mg) can cause lactic acidosis, a serious medical emergency resulting from excessive blood lactic acid (also known as Metformin-associated lactic acidosis or MALA). This rare side effect necessitates caution in patients with kidney disease, the elderly, or those who consume significant alcohol. Symptoms may include muscle pain/weakness, dizziness, fatigue, cold extremities, shortness of breath, nausea, vomiting, abdominal pain, and bradycardia. Seek immediate medical attention and discontinue Sitagliptin/Metformin if these symptoms occur.
Sitadus M 50mg/500mg tablets combine sitagliptin and metformin to treat type 2 diabetes in adults. This combination improves blood sugar control when used with diet and exercise. Metformin reduces liver glucose production and enhances insulin sensitivity, while sitagliptin boosts insulin release by inhibiting DPP-4. This medication is not suitable for individuals under 18.
Sitadus M 50mg/500mg Tablet may cause common side effects including hypoglycemia, altered taste, nausea, stomach pain, diarrhea, headache, and upper respiratory tract infections. Rare but serious side effects such as lactic acidosis may occur. Prolonged use can also result in vitamin B12 deficiency.
Patients with known allergies to Sitadus M 50mg/500mg Tablet components or excipients, or those with severe kidney or liver impairment, congestive heart failure, lactic acidosis, or diabetic ketoacidosis should not use this medication.
Combining alcohol and Sitadus M 50mg/500mg tablets is unsafe due to an increased risk of lactic acidosis.
Sitagliptin/Metformin (Sitadus M 50mg/500mg) can cause lactic acidosis (MALA), a serious medical emergency resulting from excess blood lactic acid. This rare side effect is more likely in patients with kidney disease, the elderly, or those who consume excessive alcohol. Symptoms include muscle pain/weakness, dizziness, fatigue, cold extremities, shortness of breath, nausea, vomiting, abdominal pain, and bradycardia. If these occur, discontinue Sitagliptin/Metformin and seek immediate medical attention.
Prolonged use of Sitadus M 50mg/500mg Tablets can lead to vitamin B12 deficiency by hindering its absorption. This deficiency, if left untreated, may cause anemia, neurological issues such as numbness and tingling in the extremities, weakness, urinary problems, cognitive changes, and ataxia. To mitigate this risk, annual supplemental vitamin B12 is recommended by some researchers.
Store this medication in its original, tightly closed container, following the storage instructions on the label. Discard any unused medication and ensure it's inaccessible to children, pets, and others.
Sitadus M 50mg/500mg tablets combine sitagliptin and metformin to manage type 2 diabetes in adults. This combination improves blood sugar control when used with diet and exercise. Metformin reduces liver glucose production and enhances insulin sensitivity, while sitagliptin boosts insulin release by inhibiting DPP-4. This medication is not suitable for individuals under 18.
Sitadus M 50mg/500mg Tablets may cause common side effects such as hypoglycemia, altered taste, nausea, stomach pain, diarrhea, headache, and upper respiratory tract infections. Rare but serious side effects include lactic acidosis. Prolonged use may result in vitamin B12 deficiency.
Patients with known allergies to Sitadus M 50mg/500mg Tablet components or excipients, or those with severe kidney or liver impairment, congestive heart failure, lactic acidosis, or diabetic ketoacidosis should not use this medication.
Combining Sitadus M 50mg/500mg tablets with alcohol is unsafe and may raise your risk of lactic acidosis.
Sitagliptin/Metformin (Sitadus M 50mg/500mg) can cause lactic acidosis, a serious, potentially life-threatening buildup of lactic acid in the blood (also known as MALA). This rare side effect is more likely in patients with kidney disease, older adults, or those who consume excessive alcohol. Symptoms include muscle pain or weakness, dizziness, fatigue, cold extremities, shortness of breath, nausea, vomiting, abdominal pain, and bradycardia. If you experience these, discontinue Sitagliptin/Metformin and seek immediate medical attention.
Prolonged use of Sitadus M 50mg/500mg Tablet can lead to vitamin B12 deficiency by hindering its absorption. This deficiency, if left untreated, may result in anemia, neurological issues such as numbness and tingling in the extremities, weakness, urinary problems, cognitive changes, and balance difficulties (ataxia). To mitigate this risk, annual supplemental vitamin B12 is recommended by some researchers.
Store this medication in its original, tightly closed container, following the storage instructions on the label. Discard any unused medication and keep it out of reach of children, pets, and others.
Sitadus M 50mg/500mg Tabl...
85
MRP 99
14% off